Affordable Access

Access to the full text

Enhanced renal clearance and impact on vancomycin pharmacokinetic parameters in patients with hemorrhagic stroke

  • Morbitzer, Kathryn A.1
  • Rhoney, Denise H.1
  • Dehne, Kelly A.2
  • Jordan, J. Dedrick3
  • 1 University of North Carolina at Chapel Hill, Chapel Hill, NC, USA , Chapel Hill (United States)
  • 2 UNC Health Care, Chapel Hill, NC, USA , Chapel Hill (United States)
  • 3 University of North Carolina School of Medicine, 170 Manning Drive, Physician Office Building 2118, Chapel Hill, NC, 27599, USA , Chapel Hill (United States)
Published Article
Journal of Intensive Care
BioMed Central
Publication Date
Nov 21, 2019
DOI: 10.1186/s40560-019-0408-y
Springer Nature


BackgroundThe majority of patients with hemorrhagic stroke experience enhanced renal clearance or augmented renal clearance (ARC). The purpose of this study was to determine the impact of enhanced renal clearance or ARC on vancomycin pharmacokinetic (PK) parameters.MethodsThis was a post hoc analysis of a prospective study of adult patients with aneurysmal subarachnoid hemorrhage (aSAH) or intracerebral hemorrhage (ICH) admitted to the neurosciences intensive care unit who received vancomycin. Creatinine clearance (CrCl) was measured and also estimated using the Cockcroft-Gault equation. Predicted PK parameters were compared with calculated PK parameters using serum peak and trough concentrations.ResultsSeventeen hemorrhagic stroke patients met inclusion criteria. All patients experienced enhanced renal clearance on the day that the vancomycin concentrations were obtained, and 12 patients (71%) experienced ARC. The mean calculated elimination rate constant was significantly higher than the predicted value (0.141 ± 0.02 vs. 0.087 ± 0.01 h−1; p = 0.004) and the mean calculated half-life was significantly lower than the predicted half-life (6.5 ± 0.9 vs. 8.7 ± 0.6 h; p = 0.03).ConclusionsPatients with hemorrhagic stroke and enhanced renal clearance displayed PK alterations favoring an increased elimination of vancomycin than expected. This may result in underexposure to vancomycin, leading to treatment failure.

Report this publication


Seen <100 times